Gentamicin is a recently discovered antibiotic produced from Micromonospora purpurea, highly active in vitro against such problem bacilli as Pseudomonas pyocyanea and Klebsiella pneumoniae (Klein et al., 1964; Barber and Waterworth, 1966) . Infections with these organisms have been successfully treated with gentamicin given systemically, these involving the respiratory or urinary tracts (Klein et al., 1964; Brayton and Louria, 1964) , or severe burns (Stone et al., 1965) . Pseudomonads and klebsiellae are frequently isolated nowadays from the sputum of patients with chronic respiratory disorders ; they often cause death (Pierce et al., 1966) , and may be very difficult to eliminate (Pines et al., 1963) . The in vitro and preliminary clinical experience described above suggested that gentamicin could be valuable in the treatment of these infections. We describe here our experience with this antibiotic. Colistin has been shown to be effective in certain Ps. pyocyanea infections (Halliday, 1967) . We append a note on our experiences with colistin.
Patients
During the past 12 months we have admitted to our hospital a number of cases of persistent pseudomonas or klebsiella infections of the bronchi. The patients were ill, and had not improved despite intensive and varied treatment. The antibiotics unsuccessfully used had been penicillin (9-12 megaunits daily); streptomycin (1 g. daily); tetracycline, chloramphenicol, and sometimes erythromycin (2-3 g. daily); and ampicillin or cephaloridine (4-6 g. daily). All the patients had had at least four courses chosen from these antibiotics and some many more.
Thirty-six therapeutic trials of gentamicin, given by various routes, were made in 23 patients. All were men: nine were aged 50-59 years, ten aged 60-69, and four 70 years or more. Seventeen weighed 50 to 70 kg.; the remaining six were below 50 kg. Seven of the 23 had purulent bronchiectasis; the remainder had chronic purulent bronchitis. Their general management included vigorous physiotherapy, bronchodilators, and digitalis and diuretics in some. Their illnesses were often very severe: four patients out of the eight originally selected for gentamicin treatment died while awaiting the first supplies of the drug. (Weston, 1967 Sputum levels one hour after aerosol treatment alone were 0.1-0.5 jug./ml.' in four patients, 1-2 jug./ml. in two patients, and 20 jug./ml. in one patient. Sputum levels after two hours were higher, usually 1-5 jug./ml., but in two patients were over 10 jag./ml. When intramuscular treatment alone was given, sputum levels in one patient were 0.1-0.5 jug./ml. 
Discussion
Gentamicin failed to benefit most of our patients, despite high blood levels and adequate though variable penetration into the sputum. Various routes, such as intramuscular alone, aerosol alone, or both combined, were effective in occasional patients only. These results were rather worse than those recorded by others (Klein et al., 1964; Brayton and Louria, 1964) , but it must be remembered that our patients had advanced disease and had not responded previously to the most intensive and varied antibiotic treatment.
The disc-sensitivity tests suggested that almost all of the bacteria isolated were relatively sensitive to gentamicin and might conceivably be inhibited by the concentrations reached in the blood. Why so few patients benefited is obscure. Binding of the antibiotic by mucus may have interfered with its action; a mucolytic agent could conceivably help here, but we have not tried this. The antibiotic may have been prevented from reaching the organisms by fibrosis, relative avascularity, and the presence of bronchial abscesses (Reid, 1954) , as we have postulated in similar advanced cases of bronchial infection (Pines et al., 1965) .
The significance of Ps. pyocyanea and Kl. pneumoniae in chronic purulent bronchial infections is still disputed. Their significance has sometimes been denied (May, 1953 (May, , 1954 , but they are often found in profuse growth in these patients, particularly after antibiotic treatment (Pierce et al., 1966) . Further, a characteristic necrotizing pneumonia due to these bacteria has been described at postmortem studies in such cases (Fraenkel, 1917; Pierce et al., 1966) . Though gentamicin treatment is probably more effective than other specific antibiotics available, such as colistin, treatment of these infections in the bronchi still remains a problem.
If blood levels of 10 tg./ml. are not exceeded, the medium doses of gentamicin we have used appear safe, though in two patients on this dosage such levels were reached with resulting toxic effects.
Higher levels of gentamicin resulted in more frequent toxicity and were no more effective. The doses of gentamicin we have used in these resistant infections have been several times those usually recommended.
Colistin by combined intramuscular and aerosol treatment failed completely in all patients. The patients treated successfully by Halliday (1967) appear to have had acute illnesses which were not, as in ours, superimposed upon chronic infections. Our results confirm previous impressions (Pines et al., 1963 ) that colistin has little or no place in the treatment of purulent exacerbations of chronic bronchitis.
Summary
Thirty-six trials of gentamicin were made in 23 patients suffering from chronic purulent bronchial infections. Pseudomonas pyocyanea and Klebsiella pneumoniae had been repeatedly isolated in profuse growth. The routes were intramuscular alone in medium and high doses, inhalation alone, and both combined. In only seven (19%) did the treatment succeed.
Transient toxic effects were noted in only four patients with blood levels of 1O lig. or more and in a fifth patient given high doses, where levels were not measured. Colistin in high doses was given by intramuscular injection and inhalation together to 17 patients; none benefited. Nolf (1908) first proposed the existence of a dynamic equilibrium between fibrin deposition (coagulation) and removal (fibrinolysis). This hypothesis was extended by Astrup (1956) , who envisaged a continuous deposition and removal of fibrin on the vessel walls as being a normal physiological process. He further argued that defective fibrinolysis might upset this "haemostatic balance," thus giving rise to excessive fibrin deposition, which could favour thrombosis and also be responsible for some forms of atherosclerosis according to the concept of Rokitansky (1852), elaborated by Duguid (1949 Duguid ( , 1955 . Subsequent efforts to demonstrate a defective fibrinolytic system in patients with occlusive vascular disease, by single sample analysis, have proved disappointing and controversial (Hume, 1958; Lackner and Merskey, 1960; Nestel, 1960; Ogston, 1962; Katz et al., 1963 ; Naimi et al., 1963; MacKay and Hume, 1964; Fearnley, 1965) .
It is possible that some of the present uncertainty arises from the known fact that blood fibrinolytic activity may fluctuate, in any one person, from day to day and throughout the same day (Fearnley et al., 1957 ; Blix, 1961) . Unless extreme and prolonged differences exist between patients with occlusive vascular disease and controls, comparison by single estimations could fail to provide satisfactory information. It is also possible that the significant difference between these two groups may not be found by a simple measurement of absolute resting values of fibrinolytic activity, but rather in the capacity of the fibrinolytic system to respond to physiological stimulants, including exercise (Biggs et al., 1947 ; Truelove, 1951 ; Fearnley and Lackner, 1955 ; Billimoria et al., 1959 ; Sherry et al., 1959 Ogston and Fullerton, 1961 ; Iatridis and Ferguson, 1963; jang et al., 1964; Ogston and McAndrew, 1964; Burt et al., 1964) and mental anxiety (Macht, 1952; Dreyfuss, 1956; Friedman et al., 1958; Ogston et al., 1962) .
Preliminary observations, made during the early part of a pilot study designed to test this hypothesis, showed that the fibrinolytic response (calculated as a percentage response of the pre-exercise level of the resting euglobulin lysis time) to a standardized submaximal exercise procedure was reproducible in any one individual; there were significant differences between individuals, and it was possible to isolate a group of poor responders (Cash, 1966) . It was suggested that these poor responders had a defect in their mechanisms for the production of plasminogen activator to stress, and that they might therefore be more liable to episodes of an imbalance of the coagulationfibrinolysis equilibrium as envisaged by Astrup.
It was assumed that the ability to generate plasminogen activator after exercise was, in part, genetically determined. Subsequent studies, reported in this communication, would indicate that environmental factors, in the form of prolonged mental stress, may also be relevant.
* From the South-east Scotland Regional Blood Transfusion Research
Laboratories, Royal Infirmary, Edinburgh.
Subjects
Five male medical student volunteers were studied before, during, and after a resit examination for the 2nd M.B., Ch.B. Five male age-matched control volunteers were studied simpltaneously-these were not sitting examinations but enjoying their summer vacation. 
